Yoshie Takatori-Shirakami, Mitsue Saito, Kazuhito Yokoyama. Breast Cancer. 2025 Jan;32(1):101-108
In Japan, biennial mammography screening has been recommended for the early detection of breast cancer (BC) in women aged 40 years or above since 2004 by the Ministry of Health, Labor and Welfare. We used a dynamic life table mode...
Read More
Sara P Myers, Yue Zheng, Kate Dibble, Elizabeth A Mittendorf, et al. JAMA Netw Open. 2024 Nov 4;7(11):e2446091
Young adults aged 18 to 39 years represent the minority of breast cancer diagnoses but are particularly vulnerable to financial hardship. A total 1008 patients were included (median age at diagnosis, 36 years). Patients' tumors we...
Read More
Tamara Hamlish, Michelle L Foster, Sarah Strom, et al. BMC Womens Health. 2025 Feb 25;25(1):86
We conducted descriptive statistical analysis of survey data from 315 women diagnosed with breast cancer before age 45. We found significant changes following diagnosis in employment and insurance. Prior to diagnosis, 68.6% of res...
Read More
The economic impact on individuals with breast cancer is not well understood. We sought to identify and describe the direct and indirect economic losses to breast cancer survivors in Australia. A longitudinal, population-based stu...
Read More
Melanie Lloyd, Divya Bassi, Ella Zomer, Zanfina Ademi. Cancer Epidemiol. 2025 Feb:94:102726
Breast cancer exerts a considerable burden on an individual's health but also impacts society more broadly through lost work productivity. This study aimed to measure the quality of life and productivity burden among Australian fe...
Read More
Chunhuan Lao, Mohana Mondal, Marion Kuper-Hommel, et al. Asia Pac J Clin Oncol. 2023 Aug;19(4):482-492
This study aims to identify the factors that affect the public healthcare costs of stage I-III breast cancer and stage IV cancer in New Zealand. We identified 16,977 stage I-III and 1,093 stage IV breast cancer patients eligible f...
Read More
Li Sun, Rosa Legood, Isabel Dos-Santos-Silva, et al. PLoS One. 2018 Nov 26;13(11):e0207993
This study aimed to conduct a systematic review to compare treatment costs of breast cancer by stage at diagnosis across countries at different levels of socio-economic development, and to identify key methodological differences i...
Read More
Amye J Tevaarwerk, Kris Kwekkeboom, Kevin A Buhr, et al. Cancer. 2021 Mar 1;127(5):801-808
Post cancer work limitations may affect a substantial proportion of patients and contribute to the "financial toxicity" of cancer treatment. The degree and nature of work limitations and employment outcomes are poorly understood f...
Read More
Roy A Nielsen, Eliva Atieno Ambugo, Steffen Torp, et al. J Public Health Res. 2026 Jan 26;15(1):22799036251410249
Breast cancer and its treatment may contribute to an increased risk of unemployment, influenced by both disease-related factors and socioeconomic determinant. This retrospective study investigated long-term employment among breast...
Read More
Goran Bencina, Nour Chami, Robert Hughes, et al. J Med Econ. 2023 Jan-Dec;26(1):254-261
Breast cancer (BC) poses a public health challenge as the most commonly diagnosed cancer among women globally. While BC mortality has declined across Europe in the past three decades, an opposite trend has been reported in some tr...
Read More
Agnes Brandtmüller, Anne Meiwald, Edward Oliver, et al. J Cancer Policy. 2024 Dec:42:100499
Cancer caused an estimated 2.2 million deaths across Europe in 2020. This analysis estimated the cost of lost productivity due to premature deaths associated with lung, breast and melanoma cancer and investigated the temporal tren...
Read More
Ghazaleh Pourali, Minglu Liu, Supriya S Sherpa, et al. Breast Cancer Res. 2025 Jul 1;27(1):118
Given the rising incidence of breast cancer, especially in premenopausal women, there is an urgent need to identify additional risk-reducing medications to accelerate prevention, as only a few are currently approved. Out of 8,598...
Read More